EIF4G1 and non-small cell lung carcinoma: Several key questions remain unanswered and need to be addressed in the future: 1) there is still lacking of large-scale clinical studies to investigate the expression of EIF4F complex components especially different isoforms in NSCLC biopsies, as well as their correlation with tumor stages, histology, metastasis and prognosis.